AKTIS ONCOLOGY
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor-targeting agents with ideal properties for alpha radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology's molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing the side effects of treatment. This approach would also enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes.
AKTIS ONCOLOGY
Industry:
Biotechnology Health Care Life Science
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.aktisoncology.com
Total Employee:
1+
Status:
Active
Total Funding:
156 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vida Ventures
Vida Ventures investment in Series A - Aktis Oncology
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series A - Aktis Oncology
Merck
Merck investment in Series A - Aktis Oncology
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series A - Aktis Oncology
MPM Capital
MPM Capital investment in Series A - Aktis Oncology
Bristol Myers Squibb
Bristol Myers Squibb investment in Series A - Aktis Oncology
TCG Crossover
TCG Crossover investment in Series A - Aktis Oncology
MRL Ventures Fund
MRL Ventures Fund investment in Series A - Aktis Oncology
Novartis
Novartis investment in Series A - Aktis Oncology
NS Investment
NS Investment investment in Series A - Aktis Oncology
Official Site Inspections
http://www.aktisoncology.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.27 K
- Host name: 79.148.83.34.bc.googleusercontent.com
- IP address: 34.83.148.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago